PT Medikaloka Hermina Tbk (IDX:HEAL)
Indonesia · Delayed Price · Currency is IDR 760.00
-10.00 (-1.30%)
Aug 12, 2026, 4:14 PM WIB
PT Medikaloka Hermina Tbk Ratios and Metrics
Market cap in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 11,586,731 | 21,128,181 | 24,270,749 | 21,692,778 | 22,417,924 | 15,701,180 | |
Market Cap Growth | -54.30% | -12.95% | 11.88% | -3.23% | 42.78% | 50.12% |
Enterprise Value | 16,235,502 | 25,017,928 | 28,021,821 | 24,317,744 | 24,642,985 | 18,018,084 |
Last Close Price | 760.00 | 1358.28 | 1597.02 | 1450.49 | 1501.01 | 1031.66 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 29.30 | 49.19 | 45.29 | 49.60 | 75.08 | 15.77 |
Forward PE | 21.74 | 34.23 | 34.94 | 36.69 | 42.12 | 21.13 |
PS Ratio | 1.58 | 2.96 | 3.61 | 3.75 | 4.57 | 2.68 |
PB Ratio | 1.63 | 2.93 | 4.14 | 4.17 | 4.79 | 3.54 |
P/TBV Ratio | 2.11 | 3.73 | 5.46 | 5.61 | 6.52 | 4.75 |
P/FCF Ratio | - | - | - | - | - | 24.43 |
P/OCF Ratio | 9.59 | 18.57 | 21.34 | 16.44 | 25.84 | 8.46 |
PEG Ratio | 1.53 | 2.46 | 1.30 | 11.80 | 11.80 | 0.73 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.21 | 3.51 | 4.17 | 4.20 | 5.03 | 3.07 |
EV/EBITDA Ratio | 9.11 | 14.16 | 16.08 | 16.68 | 21.66 | 8.21 |
EV/EBIT Ratio | 17.35 | 25.83 | 26.45 | 29.75 | 41.91 | 10.21 |
EV/FCF Ratio | - | - | - | - | - | 28.03 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.51 | 0.45 | 0.55 | 0.44 | 0.37 | 0.38 |
Debt / EBITDA Ratio | 2.04 | 1.82 | 1.85 | 1.54 | 1.52 | 0.76 |
Debt / FCF Ratio | - | - | - | - | - | 2.59 |
Net Debt / Equity Ratio | 0.43 | 0.35 | 0.44 | 0.27 | 0.21 | 0.09 |
Net Debt / EBITDA Ratio | 1.73 | 1.41 | 1.49 | 0.96 | 0.85 | 0.17 |
Net Debt / FCF Ratio | -8.92 | -4.08 | -2.27 | -5.17 | -3.68 | 0.59 |
Asset Turnover | 0.62 | 0.64 | 0.69 | 0.71 | 0.65 | 0.84 |
Inventory Turnover | 39.21 | 31.62 | 34.41 | 35.54 | 34.24 | 34.97 |
Quick Ratio | 1.17 | 1.11 | 1.04 | 1.17 | 0.98 | 1.46 |
Current Ratio | 1.27 | 1.22 | 1.13 | 1.26 | 1.05 | 1.53 |
Return on Equity (ROE) | 7.28% | 8.40% | 12.46% | 11.32% | 8.31% | 33.03% |
Return on Assets (ROA) | 4.89% | 5.39% | 6.83% | 6.23% | 4.85% | 15.84% |
Return on Invested Capital (ROIC) | 6.64% | 7.75% | 10.69% | 10.51% | 8.87% | 31.54% |
Return on Capital Employed (ROCE) | 9.10% | 9.70% | 12.10% | 11.30% | 10.00% | 29.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 3.43% | 2.03% | 2.21% | 2.02% | 1.33% | 6.34% |
FCF Yield | -2.97% | -2.90% | -4.71% | -1.25% | -1.17% | 4.09% |
Dividend Yield | 1.36% | - | 0.66% | 0.59% | 0.47% | 0.58% |
Payout Ratio | 51.73% | 36.19% | 23.61% | 23.20% | 29.02% | 7.38% |
Buyback Yield / Dilution | -3.06% | -1.90% | -0.88% | 0.01% | 1.31% | -0.16% |
Total Shareholder Return | -1.72% | -1.90% | -0.22% | 0.60% | 1.77% | 0.43% |